Simplex Trading, LLC Chinook Therapeutics, Inc. Transaction History

Simplex Trading, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 04, 2023	BUY	$18.66 - $38.58 $476,539 - $985,256	25,538 New	25,538 $981,000
Q2 2022 Aug 03, 2022	SELL	$12.59 - $18.8 $22,624 - $33,783	-1,797 Closed	0 $0
Q1 2022 May 02, 2022	BUY	$12.02 - $16.69 $18,474 - $25,652	1,537 Added 591.15%	1,797 $29,000
Q2 2021 Aug 12, 2021	BUY	$13.6 - $18.98 $3,536 - $4,934	260 New	260 $3,000

234K

Ticker KDNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,896,300
Description
Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases. The company's lead clinical program is atrasentan, a Phase III endothelin receptor antagonist for the treatment of IgA nephropathy and other proteinuric glomerular diseases. ...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.